News


Dr. Druley discusses novel technologies to detect minimal residual disease (MRD) at the American Society of Hematology (ASH) Congress 2016 in San Diego, CA.

Todd E. Druley, MD, from the Washington University School of Medicine in St. Louis, St. Louis, MO, discusses novel technologies to detect minimal residual disease (MRD) at the American Society of Hematology (ASH) Congress 2016 in San Diego, CA. He explains that minimal residual disease (MRD) is the assessment for […]